Information for Connecticut Prescribing Practitioners and Pharmacists Pursuant to Public Act No. 23-171
PharmaEssentia USA Corporation (“PharmaEssentia”) provides the following information to Connecticut prescribing practitioners and pharmacists pursuant to Public Act No. 23-171. The price listed below is Wholesale Acquisition Cost (“WAC”) established and made available to the public by a third-party publisher.
| NDC | Product Name | Strength | Package Size | WAC Price |
|---|---|---|---|---|
| 73536-500-01 | BESREMi® (ropeginterferon alfa-2b- njft) | 500 mcg/ml | 1 syringe | $10,421 USD |
Information on the variation efficacy of the legend drug marketed to different racial and ethnic groups: None
The price listed is WAC price, which represents PharmaEssentia’s published wholesale list price for the product before any discount, rebate, or other price reduction. The WAC price listed may differ significantly from actual prices paid by customers and consumers. In addition, a product’s WAC is typically not associated with per-dose pricing, and does not necessarily reflect price per dosage, price per course of treatment or the cost effectiveness of the products listed.
Pricing information listed does not imply safety or efficacy of the product. Please refer to the product’s FDA-approved label and indication for further information at: https://us.pharmaessentia.com/downloads/Besremi_USPI_ENG.pdf
Data as of May 15, 2026
© 2026 PharmaEssentia Corporation. All rights reserved. BESREMi, the BESREMi logo, and PharmaEssentia are registered trademarks of PharmaEssentia Corporation.
US-BSRM-2300203 (v5.0) 05/2026